A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
12/2004
12/08/2004	CN1178688C Health-care food for resisting fatigue
12/08/2004	CN1178678C Process for preparing arnebia root medicine with broad-spectrum medical functions
12/08/2004	CN1178671C Egg anti-inflammatory composition and isolation method and use
12/08/2004	CN1178670C Process for prodn. of biological prepn. for antisenesence
12/08/2004	CN1178663C Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
12/08/2004	CN1178660C Antiviral combinations of lamivudine and adefovir
12/08/2004	CN1178658C Process for synthesizing Cox-2 inhibitors
12/07/2004	US6828462 Amines such as 3,3,5,5-Tetramethyl-1-vinylcyclohexanamine hydrochloride, used as N-methyl-D-aspartate (NMDA), serotonin and nicotinic acetylcholine receptor antagonists
12/07/2004	US6828456 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors
12/07/2004	US6828447 Therapeutic agent for use in the treatment of cardiovascular and inflammatory disorders
12/07/2004	US6828446 Aromatic thioether liver X-receptor modulators
12/07/2004	US6828440 Analgesics; side effect reduction
12/07/2004	US6828424 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent
12/07/2004	US6828350 Inhibiting the activity of a picornavirus 3C protease or a cysteine protease with a composition having an orthohydroxy keto aryl core structure
12/07/2004	US6828348 L-ascorbic acid-2-o-maleic acid-a-tocopherol diester 1-propanol adduct and process for producing the same
12/07/2004	US6828343 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
12/07/2004	US6828341 Brain disorders; anticonvulsants; central nervous system disorders; psychological disorders
12/07/2004	US6828338 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
12/07/2004	US6828337 Bicyclic retinods containing ester or acid group; useful for treating emphysema
12/07/2004	US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/07/2004	US6828333 Ether derivatives useful as inhibitors of PDE4 isozymes
12/07/2004	US6828332 Piperidine derivatives as reuptake inhibitors
12/07/2004	US6828330 Quinuclidine-substituted hetero-bicyclic aromatic compounds for the treatment of disease
12/07/2004	US6828327 Macroheterocylic compounds useful as kinase inhibitors
12/07/2004	US6828325 A benzoxazolopiperazine derivative useful for treating Parkinson's diseases, schizophrenia, anxiety and depression
12/07/2004	US6828322 Triazolo-pyridazine derivatives as ligands for GABA receptors
12/07/2004	US6828319 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
12/07/2004	US6828318 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
12/07/2004	US6828315 1-Amino triazoloc4,3-a! quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV
12/07/2004	US6828314 Modulation of the activity of serotonin receptors (5-HT) to treat diseases such as anxiety, depression or obesity
12/07/2004	US6828298 Glycoprotein having inhibitory activity against helicobacter pylori colonization
12/07/2004	US6827951 Composition and method for smoke detoxification
12/07/2004	US6827946 Compositions containing both sedative and non-sedative antihistamines
12/07/2004	US6827931 Method for treating endocrine disorders
12/07/2004	US6827929 Scar treatment composition
12/07/2004	CA2316921C Aryl fused azapolycyclic compounds
12/07/2004	CA2208673C Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin
12/07/2004	CA2154668C Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
12/07/2004	CA2150123C Aminomethylene substituted non-aromatic heterocycles
12/07/2004	CA2147755C 6-(substituted methylene) penems and intermediates
12/07/2004	CA2108817C Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
12/02/2004	WO2004104038A1 Control of the intracellular localization of ip3 receptor
12/02/2004	WO2004103992A1 2-aminoquinoline derivative
12/02/2004	WO2004103974A1 Substituted 2-oxoquinoline compound and medicinal use thereof
12/02/2004	WO2004103971A1 Cyclic aminophenyl sulfamate derivative
12/02/2004	WO2004103954A1 Amide derivative
12/02/2004	WO2004103393A1 CONTROL OF FUNCTION OF INTRACELLULAR Ca ION
12/02/2004	WO2004026815A3 Phenol derivatives and their use as rotamase inhibitors
12/02/2004	WO2003095667A3 Autoimmune conditions and nadph oxidase defects
12/02/2004	WO2003085377A3 Novel pancortin-pablo protein interactions and methods of use thereof
12/02/2004	WO2003078465A8 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
12/02/2004	WO2003064387A3 Substituted indoles as alpha-1 agonists
12/02/2004	WO2003039452A3 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
12/02/2004	WO2003025119A3 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
12/02/2004	WO2003011106A3 Internal image antibodies for optical imaging and therapy
12/02/2004	US20040243316 Crystallographic structure of the androgen receptor ligand binding domain
12/02/2004	US20040243097 Antiproliferative drug and delivery device
12/02/2004	US20040242928 Reverse hydroxamic acid derivatives
12/02/2004	US20040242871 Nitric oxide synthease inhibitors; antiinflamamtory agents; analgesics; inflamamtory bowel disorders; antiarthritic agents;
12/02/2004	US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004	US20040242860 Compositions and methods for the diagnosis and treatment of tumor
12/02/2004	US20040242853 Glp-1 exendin-4 peptide analogs and uses thereof
12/02/2004	US20040242842 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use
12/02/2004	US20040242701 Amines as ant-alcoholism agents
12/02/2004	US20040242700 Administering a warm blood animal an ambroxol, bromhexin or salts or mixtures for treating influenza virus
12/02/2004	US20040242694 Remedial agent for cardiac failure
12/02/2004	US20040242685 Administering -4-benzyloxy-3,5-dimethoxy-N-[(1-dimethylaminocyclopentyl)methyl]benzamide or derivatives for treating disorders responsive to inhibition of the GlyT-2 transporter, such as muscle spasticity, epilepsy and acute, chronic and neuropathic pain
12/02/2004	US20040242682 Compositions comprising arginine and nitrates
12/02/2004	US20040242678 Apolipo protein e secretion promoters
12/02/2004	US20040242675 Compositions useful for the treatment of pathologies responding to the activation of PPAR-gamma receptor
12/02/2004	US20040242672 Pyrrolidine derivatives
12/02/2004	US20040242671 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug
12/02/2004	US20040242660 Combinations of oxazolidinones with other active ingredients for the prophylaxis and/or treatment of thromboembolic disorders
12/02/2004	US20040242659 Heterocyclic compounds, oxazole derivatives, process for preparation of the same and use thereof
12/02/2004	US20040242656 N-heterocyclicamide compounds; useful in the treatment of cardiovascular disorders, in particular, as an anticoagulant
12/02/2004	US20040242651 to gastrointestal systems, kidneys
12/02/2004	US20040242640 Dual-release compositions of a cyclooxygenase-2 inhibitor
12/02/2004	US20040242633 Compound used to lower cholesterol, reduce weight for dietetics, antidepressants and antidiabetic agents
12/02/2004	US20040242629 Quinuclidine carbamate derivatives and their use as M3 antagonists
12/02/2004	US20040242628 administering N-(1H-Indol-7-yl)-4-nitrobenzenesulfonamide; treating cachexia during cancer therapy
12/02/2004	US20040242627 2-Iminoimidazole derivatives (1)
12/02/2004	US20040242617 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
12/02/2004	US20040242605 Medicine containing pyrimidine derivative
12/02/2004	US20040242600 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumur
12/02/2004	US20040242598 Phosphodiesterase 4 inhibitors
12/02/2004	US20040242597 Combination
12/02/2004	US20040242595 Pyrimidine derivatives
12/02/2004	US20040242592 2-Substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
12/02/2004	US20040242591 phenyloxazolidinones derivatives that exhibit significantly greater antibacterial activity, than available with the present compounds against multiply resistant gram positive pathogens
12/02/2004	US20040242589 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
12/02/2004	US20040242584 Muscarinic agonists
12/02/2004	US20040242574 Anticancer agents; antiarthritic agents
12/02/2004	US20040242573 Novel compounds
12/02/2004	US20040242564 1,2,3,4-tetrahydroisoquinolines derivatives
12/02/2004	US20040242539 Method of enhancing lysosomal alpha-galactosidase A
12/02/2004	US20040242538 Method to improve complexation efficacy and produce high-energy cylodextrincomplexes
12/02/2004	US20040242508 Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing the same
12/02/2004	US20040242507 Topical formulations of a lipophilic anthracycline with a second active ingredient and carrier; antiproliferative agents for skin and mucus membrane disorders; side effect reduction in psoriasis treatment with valrubicin
12/02/2004	US20040242503 Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease
12/02/2004	US20040242499 For example, N-[2- beta -D-galactopyranosylthio-1-(tetradecylcarbamoyl)ethyl]octadecanoylamide or N-[2-( beta -D-galactopyranosyloxy)ethyl]octadecanoylamide; for treating rough skin

1 ... 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 ... 1564